Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RE-ALIGN: Dabigatran in Mechanical Heart Valve Replacement
NCT01452347Phase 2Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2011
- Primary completion
- Jun 2013
- Countries
- 10
01
Overview
A Phase 2 trial of dabigatran in heart valve disease, sponsored by Boehringer Ingelheim. Started Oct 2011; status: terminated.
02
Drugs
dabigatran
03
Conditions
heart valve disease
Beyond the preview
Go deeper on NCT01452347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01452347.